SGHT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sight Sciences Inc (SGHT) does not present a strong buy opportunity at this time for a beginner, long-term investor with $50,000-$100,000 to invest. The stock is currently in a pre-market decline (-7.41%), with no significant positive catalysts, weak financial performance, and neutral trading sentiment. Analysts have consistently lowered price targets, and there are no recent signals from Intellectia Proprietary Trading Signals to support a buy decision.
The MACD is positive but contracting, RSI is neutral at 74.453, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot point of 4.191, with resistance at 4.873 and support at 3.509. Overall, technical indicators suggest a lack of strong momentum.
NULL identified. No recent news or significant positive developments. The company's gross margin increased slightly YoY to 87.26%, which is a minor positive.
Financial performance in Q4 2025 showed a significant drop in net income (-64.87% YoY) and EPS (-65.22% YoY). No recent congress trading data or insider buying activity.
In Q4 2025, revenue increased by 6.87% YoY to $20.385M, but net income dropped by -64.87% YoY to -$4.162M, and EPS fell by -65.22% YoY to -$0.08. Gross margin improved slightly to 87.26%, up 0.50% YoY.
Analysts have a mixed to neutral view on SGHT. Citi recently lowered its price target to $4.35 and maintained a Neutral rating. UBS lowered its target to $11 but kept a Buy rating. Stifel raised its target to $8 with a Buy rating. Overall, there is no strong consensus for a buy.
